DK170339B1 - Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler - Google Patents

Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler Download PDF

Info

Publication number
DK170339B1
DK170339B1 DK630088A DK630088A DK170339B1 DK 170339 B1 DK170339 B1 DK 170339B1 DK 630088 A DK630088 A DK 630088A DK 630088 A DK630088 A DK 630088A DK 170339 B1 DK170339 B1 DK 170339B1
Authority
DK
Denmark
Prior art keywords
azelastine
embonate
suspension
preparation
acid
Prior art date
Application number
DK630088A
Other languages
Danish (da)
English (en)
Other versions
DK630088D0 (da
DK630088A (da
Inventor
Gerhard Scheffler
Dieter Sauerbier
Juergen Engel
Original Assignee
Asta Medica Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Medica Ag filed Critical Asta Medica Ag
Publication of DK630088D0 publication Critical patent/DK630088D0/da
Publication of DK630088A publication Critical patent/DK630088A/da
Application granted granted Critical
Publication of DK170339B1 publication Critical patent/DK170339B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK630088A 1987-11-13 1988-11-11 Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler DK170339B1 (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3738641 1987-11-13
DE3738641 1987-11-13
SG153894A SG153894G (en) 1987-11-13 1994-10-21 Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient
SG153894 1994-10-21

Publications (3)

Publication Number Publication Date
DK630088D0 DK630088D0 (da) 1988-11-11
DK630088A DK630088A (da) 1989-05-14
DK170339B1 true DK170339B1 (da) 1995-08-07

Family

ID=25861795

Family Applications (1)

Application Number Title Priority Date Filing Date
DK630088A DK170339B1 (da) 1987-11-13 1988-11-11 Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler

Country Status (9)

Country Link
EP (1) EP0316639B1 (ja)
JP (1) JP2730581B2 (ja)
AT (1) ATE106883T1 (ja)
CA (1) CA1317595C (ja)
DE (1) DE3850044D1 (ja)
DK (1) DK170339B1 (ja)
ES (1) ES2053679T3 (ja)
HK (1) HK135494A (ja)
SG (1) SG153894G (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0396069T3 (da) * 1989-05-05 1994-07-25 Asta Medica Ag Salte af azelastin med forbedret opløselighed
JPH04198180A (ja) * 1990-11-28 1992-07-17 Eezai Kagaku Kk ベンジルフタラゾン誘導体の製造方法
US20070020330A1 (en) 2004-11-24 2007-01-25 Medpointe Healthcare Inc. Compositions comprising azelastine and methods of use thereof
US8758816B2 (en) 2004-11-24 2014-06-24 Meda Pharmaceuticals Inc. Compositions comprising azelastine and methods of use thereof
NZ555501A (en) 2004-11-24 2010-01-29 Medpointe Healthcare Inc Compositions comprising azelastine and methods of use thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH572914A5 (ja) * 1971-01-22 1976-02-27 Asta Werke Ag Chem Fab

Also Published As

Publication number Publication date
DK630088D0 (da) 1988-11-11
SG153894G (en) 1995-03-17
EP0316639B1 (de) 1994-06-08
JP2730581B2 (ja) 1998-03-25
DK630088A (da) 1989-05-14
DE3850044D1 (de) 1994-07-14
HK135494A (en) 1994-12-09
ES2053679T3 (es) 1994-08-01
ATE106883T1 (de) 1994-06-15
EP0316639A2 (de) 1989-05-24
CA1317595C (en) 1993-05-11
JPH01153686A (ja) 1989-06-15
EP0316639A3 (en) 1990-07-18

Similar Documents

Publication Publication Date Title
US10034876B2 (en) Liquid formulations of salts of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]-piperazine
TWI632921B (zh) 口服溶液
US5232919A (en) Azelastine embonate and compositions which contain it
EP2648696B1 (en) New form of administration of racecadotril
TWI635875B (zh) 包含左旋西替利及蒙特魯卡斯特之具有經改良的穩定性之錯合物顆粒調配物
DK170339B1 (da) Azelastinembonat, fremgangsmåde til fremstilling deraf, præparater med indhold af, og stabile, vandige suspensioner af denne forbindelse, samt anvendelse af azelastinembonat til fremstilling af lægemidler
JP2021520367A (ja) アムロジピン製剤
KR101553565B1 (ko) 몬테루카스트 또는 그의 약제학적으로 허용 가능한 염, 및 산성 안정화제를 포함하는 안정성이 개선된 시럽 제제 및 그의 제조 방법
JP2008524318A (ja) 安定なアジスロマイシン非二水和物の経口用懸濁液剤
JP3792514B2 (ja) セルトラリン経口濃縮物
KR101513848B1 (ko) 몬테루카스트 및 그의 약제학적으로 허용 가능한 염을 포함하는 안정성이 개선된 시럽 제제 및 그의 제조 방법
US20170157108A1 (en) Liquid formulation comprising montelukast or pharmaceutically acceptable salt thereof and method for preparing same
NO329041B1 (no) Farmasoytisk sammensetning
TW201622701A (zh) 包含蒙特魯卡斯特或其藥學上可接受之鹽類之具有增進之安定性的液體調配物及其製備方法
WO2013062497A1 (en) Liquid pharmaceutical formulations
JPH10511640A (ja) サベルゾール経口懸濁剤
US20030104017A1 (en) Epinastine formulation for oral administration
US20210387984A1 (en) Hemi (l)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2-yl}methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one and pharmaceutical compositions comprising the same
IE64051B1 (en) Azelastine embonate process for its preparation and pharmaceutical preparations which contain azelastine embonate as active substance
KR20200138556A (ko) 몬테루카스트 또는 그의 약제학적으로 허용가능한 염을 포함하는 시럽 조성물
WO2024047474A1 (en) Trientine liquid dosage forms
JP2000512307A (ja) 医薬として用いる、トリプタミン由来のアリールピペラジンのメタンスルホン酸塩およびその溶媒和物
KR20150035286A (ko) 몬테루카스트 또는 그의 약제학적으로 허용 가능한 염을 포함하는 광 안정성이 개선된 시럽 제제 및 그의 제조 방법
OA16449A (en) New form of administration of enkephalinase inhibitor.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired